Ticarcillin plus clavulanic acid versus moxalactam therapy of osteomyelitis, septic arthritis, and skin and soft tissue infections
- 29 November 1985
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 79 (5) , 141-145
- https://doi.org/10.1016/0002-9343(85)90148-2
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- In Vitro and in Vivo Antibacterial Activity of Moxalactam, an Oxa-β-Lactam AntibioticClinical Infectious Diseases, 1982
- The New Beta-Lactamase-Stable CephalosporinsAnnals of Internal Medicine, 1982
- Infection and diabetes: The case for glucose controlThe American Journal of Medicine, 1982
- Polymicrobial Osteomyelitis: Report of Three Cases and Review of the LiteratureClinical Infectious Diseases, 1982
- Osteomyelitis: The Past DecadeNew England Journal of Medicine, 1980
- Acute nongonococcal infectious arthritisArthritis & Rheumatism, 1980
- In vitro synergistic properties of clavulanic acid, with ampicillin, amoxycillin and ticarcillinJournal of Antimicrobial Chemotherapy, 1980
- Combined Activity of Clavulanic Acid and Ticarcillin Against Ticarcillin-Resistant, Gram-Negative BacilliAntimicrobial Agents and Chemotherapy, 1978
- Ticarcillin for Treatment of Serious Infections with Gram-Negative BacteriaThe Journal of Infectious Diseases, 1976
- A Five-Year Prospective Study of 23,649 Surgical WoundsArchives of Surgery, 1973